![Robbie Woodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robbie Woodman
Directeur/Membre du Conseil chez
Emendo Biotherapeutics, Inc.
Profil
Robbie Woodman is currently Director at Emendo Biotherapeutics, Inc., Principal at Touchstone Innovations Investment Management Ltd., and Partner at Panakes Partners SGR SpA since 2021.
Former roles include Chairman at Harness Therapeutics Ltd., Director healthcare ventures at Touchstone Innovations Investment Management Ltd., Non Executive Director at Obsidian Therapeutics, Inc., BiomX, Inc., Catamaran Bio, Inc. (2020-2021), and Abintus Bio, Inc., Principal at Sofinnova Partners SAS, and Senior Partner at Takeda Ventures, Inc. (2018-2021).
Education includes graduate degrees from the University of Oxford and the University of Cambridge.
Postes actifs de Robbie Woodman
| Sociétés | Poste | Début |
|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Directeur/Membre du Conseil | - |
Panakes Partners SGR SpA
 Panakes Partners SGR SpA Investment ManagersFinance Panakes Partners invests in small and mid-market companies located across the globe primarily in Europe. The firm targets companies operating in the life sciences sector. It participates in early stage capital requirements. | Private Equity Investor | 01/09/2021 |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance IIIM is an active manager which invests in technology businesses based on intellectual property from Imperial College. The company also invests in companies that have been through the incubation process managed by the Imperial Innovations' New Ventures team. The firm leads or co-leads investment rounds in technology companies across all stages of development in the healthcare, energy, environment and emerging technology sectors. Companies seeking first round funding and beyond are expected to have demonstrated that they have recruited of an experienced CEO and CTO, have a functioning board including an experienced Chairman and at least one non-executive director appointed by IIIM, have financial controls and responsible financial management, have resolved initial intellectual property technical risk, have a clear, credible and commercial business plan and have identified a location for the company to achieve full independence IIIM works toward exits through trade sales, mergers or IPOs. | Corporate Officer/Principal | - |
Anciens postes connus de Robbie Woodman
| Sociétés | Poste | Fin |
|---|---|---|
Transine Therapeutics Ltd.
 Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Président | 27/01/2025 |
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Private Equity Investor | 01/09/2021 |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Corporate Officer/Principal | 01/09/2021 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Corporate Officer/Principal | - |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance IIIM is an active manager which invests in technology businesses based on intellectual property from Imperial College. The company also invests in companies that have been through the incubation process managed by the Imperial Innovations' New Ventures team. The firm leads or co-leads investment rounds in technology companies across all stages of development in the healthcare, energy, environment and emerging technology sectors. Companies seeking first round funding and beyond are expected to have demonstrated that they have recruited of an experienced CEO and CTO, have a functioning board including an experienced Chairman and at least one non-executive director appointed by IIIM, have financial controls and responsible financial management, have resolved initial intellectual property technical risk, have a clear, credible and commercial business plan and have identified a location for the company to achieve full independence IIIM works toward exits through trade sales, mergers or IPOs. | Private Equity Investor | - |
Formation de Robbie Woodman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance IIIM is an active manager which invests in technology businesses based on intellectual property from Imperial College. The company also invests in companies that have been through the incubation process managed by the Imperial Innovations' New Ventures team. The firm leads or co-leads investment rounds in technology companies across all stages of development in the healthcare, energy, environment and emerging technology sectors. Companies seeking first round funding and beyond are expected to have demonstrated that they have recruited of an experienced CEO and CTO, have a functioning board including an experienced Chairman and at least one non-executive director appointed by IIIM, have financial controls and responsible financial management, have resolved initial intellectual property technical risk, have a clear, credible and commercial business plan and have identified a location for the company to achieve full independence IIIM works toward exits through trade sales, mergers or IPOs. | Finance |
Panakes Partners SGR SpA
Panakes Partners SGR SpA Investment ManagersFinance Panakes Partners invests in small and mid-market companies located across the globe primarily in Europe. The firm targets companies operating in the life sciences sector. It participates in early stage capital requirements. | Finance |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Health Technology |
Abintus Bio, Inc.
 Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage gene therapy company | Commercial Services |
Transine Therapeutics Ltd.
Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Choisissez Zonebourse 
